Young person in a library, longtime fan of effectiveness and altruism / first-time forum poster
0x799
Karma: 11
Tuberculosis: Prepare to fund new MDR-TB regimens?
Thanks! I don’t use LinkedIn—is it within the bounds of propriety to tag his EA Forum account here?
Ah—where are you seeing that? The endTB page mentions under “What’s next?” the phase III endTB-Q trial, but that’s for pre-XDR TB, with “results [...] expected in late 2024″.
“directly observed therapy, short-chouse (DOTS) coverage” looks like a somewhat confusing typo of “directly observed therapy, short-course (DOTS) coverage”, unless I’m about to learn a new medical term.